Literature DB >> 33467637

Prolonged Carriage of Carbapenemase-Producing Enterobacteriaceae: Clinical Risk Factors and the Influence of Carbapenemase and Organism Types.

Yong Kyun Kim1, In Bok Chang2, Han Sung Kim3, Wonkeun Song4, Seung Soon Lee5.   

Abstract

Prolonged carriage of carbapenemase-producing Enterobacteriaceae (CPE) constitutes a substantial epidemiologic threat. This study aimed to evaluate whether the types of carbapenemase and organism can affect the duration of carriage and to evaluate the clinical factors associated with prolonged carriage. We retrospectively reviewed data for patients admitted between May 2013 and August 2018 who were identified as CPE carriers. A total of 702 patients were identified; the major types of carbapenemase and organism were Oxacillinase (OXA)-48-like (n = 480, 68.4%) and Klebsiella pneumoniae (K. pneumoniae) (n = 584, 83.2%). The analyses of time to spontaneous decolonization using the Kaplan-Meier method showed that OXA-48-like and K. pneumoniae were significantly associated with prolonged carriage (log rank, p = 0.001 and p < 0.001). In multivariable logistic analysis to assess the risk factors for CPE prolonged carriage in the 188 patients with available follow-up culture data for 3 months, K. pneumoniae (adjusted odds ratio [aOR] 6.58; 95% confidence interval [CI], 1.05-41.27; p = 0.044), CPE positive clinical specimen (aOR 11.14; 95% CI, 4.73-26.25; p < 0.001), and concurrent Clostridioides difficile infection (CDI) (aOR 3.98, 95% CI 1.29-12.26; p = 0.016) were predictive of prolonged carriage. Our results suggest that CP-K. pneumoniae may have higher probability of prolonged carriage, while the effect of OXA-48-like CPE is inconclusive. Furthermore, patients with CP-K. pneumoniae who had positive clinical specimen or concurrent CDI can cause a vicious circle in prolonged carriage.

Entities:  

Keywords:  carbapenemase; carbapenemase-producing Enterobacteriaceae; organism; prolonged carriage

Year:  2021        PMID: 33467637      PMCID: PMC7830152          DOI: 10.3390/jcm10020310

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  39 in total

1.  Active surveillance for asymptomatic carriers of carbapenemase-producing Klebsiella pneumoniae in a hospital setting.

Authors:  C Gagliotti; V Ciccarese; M Sarti; S Giordani; A Barozzi; C Braglia; C Gallerani; R Gargiulo; G Lenzotti; O Manzi; D Martella; M L Moro
Journal:  J Hosp Infect       Date:  2013-02-12       Impact factor: 3.926

2.  Long-term carriage of Klebsiella pneumoniae carbapenemase-2-producing K pneumoniae after a large single-center outbreak in Germany.

Authors:  Christoph Lübbert; Norman Lippmann; Thilo Busch; Udo X Kaisers; Tanja Ducomble; Tim Eckmanns; Arne C Rodloff
Journal:  Am J Infect Control       Date:  2014-04       Impact factor: 2.918

3.  Comparing the Outcomes of Patients With Carbapenemase-Producing and Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae Bacteremia.

Authors:  Pranita D Tamma; Katherine E Goodman; Anthony D Harris; Tsigereda Tekle; Ava Roberts; Abimbola Taiwo; Patricia J Simner
Journal:  Clin Infect Dis       Date:  2016-11-09       Impact factor: 9.079

Review 4.  Carbapenem-Resistant Enterobacteriaceae: A Strategic Roadmap for Infection Control.

Authors:  N Deborah Friedman; Yehuda Carmeli; Aaron Lea Walton; Mitchell James Schwaber
Journal:  Infect Control Hosp Epidemiol       Date:  2017-03-15       Impact factor: 3.254

5.  Dissemination of multiple carbapenem resistance genes in an in vitro gut model simulating the human colon.

Authors:  C M Rooney; A E Sheppard; E Clark; K Davies; A T M Hubbard; R Sebra; D W Crook; A S Walker; M H Wilcox; C H Chilton
Journal:  J Antimicrob Chemother       Date:  2019-07-01       Impact factor: 5.790

6.  Clinical factors predicting persistent carriage of Klebsiella pneumoniae carbapenemase-producing carbapenem-resistant Enterobacteriaceae among patients with known carriage.

Authors:  Y K Kim; S A Song; J N Lee; M Oh; K M Jo; H-J Kim; J H Lee; J Park; H-J Jang; H-K Kim; S Kiem
Journal:  J Hosp Infect       Date:  2017-10-27       Impact factor: 3.926

7.  A Novel Risk Factor Associated With Colonization by Carbapenemase-Producing Enterobacteriaceae: Use of Proton Pump Inhibitors in Addition to Antimicrobial Treatment.

Authors:  Vincent C C Cheng; Jonathan H K Chen; Simon Y C So; Sally C Y Wong; Pui-Hing Chau; Lisa M W Wong; Radley H C Ching; Modissa M L Ng; Wan-Mui Lee; Ivan F N Hung; Pak-Leung Ho; Kwok-Yung Yuen
Journal:  Infect Control Hosp Epidemiol       Date:  2016-09-13       Impact factor: 3.254

8.  Fecal Microbial Transplants Reduce Antibiotic-resistant Genes in Patients With Recurrent Clostridium difficile Infection.

Authors:  Braden Millan; Heekuk Park; Naomi Hotte; Olivier Mathieu; Pierre Burguiere; Thomas A Tompkins; Dina Kao; Karen L Madsen
Journal:  Clin Infect Dis       Date:  2016-03-29       Impact factor: 9.079

9.  Prevalence and Molecular Characteristics of Carbapenemase-Producing Enterobacteriaceae From Five Hospitals in Korea.

Authors:  Seok Hoon Jeong; Han Sung Kim; Jae Seok Kim; Dong Hoon Shin; Hyun Soo Kim; Min Jeong Park; Saeam Shin; Jun Sung Hong; Seung Soon Lee; Wonkeun Song
Journal:  Ann Lab Med       Date:  2016-11       Impact factor: 3.464

10.  The rate of acquisition of carbapenemase-producing Enterobacteriaceae among close contact patients depending on carbapenemase enzymes.

Authors:  Jung Wan Park; Sun Hee Kwak; Jiwon Jung; Jeong Young Lee; Young Ju Lim; Hye Suk Choi; Min Jee Hong; Sang Ho Choi; Mi Na Kim; Sung Han Kim
Journal:  Infect Chemother       Date:  2020-02-20
View more
  1 in total

1.  Occurrence and Characteristics of Carbapenem-Resistant Klebsiella pneumoniae Strains Isolated from Hospitalized Patients in Poland-A Single Centre Study.

Authors:  Jolanta Sarowska; Irena Choroszy-Krol; Agnieszka Jama-Kmiecik; Beata Mączyńska; Sylwia Cholewa; Magdalena Frej-Madrzak
Journal:  Pathogens       Date:  2022-07-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.